At meeting held on 23 April 2022
The Board of Advik Laboratories at its meeting held on 23 April 2022 has considered and withdrawn the proposed preferential allotment of up to 2.50 crore convertible warrants of Rs 10 each and the proposed increased in authorised share capital from Rs 20 crore to Rs 45 crore.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
